doi: 10.1016/j.tem.2024.05.002 Summary Keywords food preferences, gastrointestinal hormones, glucagon-like peptide 1, gut-brain axis, obesity, taste, taste receptors Citation Doval-Caballero JLE, Ferreira-Hermosillo A, Eugenio-Ponce GD, Garca-Senz MR, Ibarra-Salce R, Tenorio-Rojo AP, Luna-Avila ES, Gete-Palacios PC, Prez-Hernndez F, Rojas-Miln E, Lpez-Cruz LA and Mndez-Hernndez CA (2026) Potential role of glucagon like peptide 1 in taste receptors
Retatrutide vs ozempic Ozempic is the brand name for semaglutide in its injectable form
NMN (-Nicotinamide Mononucleotide): a direct precursor to NAD that enhances cellular energy metabolism and may promote longevity and vitality
angiotensin IV analogue Sequence (formal name): N-hexanoic-Tyr-Ile-(6) aminohexanoic amide IUPAC name: 6-[(2S,3S)-2-[(2S)-2-hexanamido-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]hexanamide Synonyms: PNB-0408, Hexanoyl-Tyr-Ile-Ahx-NH 2 , MM-201 (older designation) CAS Number: 1401708-83-5 Molecular Formula: C 27 H 44 N 4 O 5 Molecular Weight: 504.66 g/mol Solubility: slightly soluble in DMSO and methanol
Every 60 to 90 minutes, a reminder to drink 200 mL
Integrating Weight Loss Into Musculoskeletal Care GLP-1 medications like semaglutide are reshaping how we approach obesity treatment, offering many patients the chance to improve metabolic health, reduce joint pain, and regain functional mobility